BrightOwl Loader Loading

Summary

PROFESSIONAL EXPERIENCE -

- Oral presentation and writing skills - Fifteen publications in international peer-reviewed journals, two chapters in books (list added in annex). Nine oral en seventeen poster presentations on national and international congresses - Experience in student guidance and counselling

- Preparing and presenting overview statements on current issues in the medical community (cardiology, pulmunology, rheumatology)

- Organization and execution of discussions, workshops and advisory boards on several health-related issues (cardiology, pulmunology, rheumatology), seeking advice from European medical opinion leaders

- Brand Team lead (Symbicort, Brilique) driving and aligning marketing, medical, sales, market access, market research departments towards a common goal

- Launch of BRILIQUE (interventional cardiology) in the Belgian and GD Lux market (Brand Leader)

- Worked as market access responsible in diabetes, cardiology and infectious disease in Belgium and GD Luxemburg

- Responsible for Pharmacovigilance oversight for JBV products (Remicade, Simponi, ReoPro) in rheumatology, gastroenterology and psoriatic disease in the EMEA region (Europe, Middle East and Africa) 

 

Experiences

Current Experience

  • Associate Director Pharmacovigilance and Risk Management
    Since September 2013
    This position has been established to provide oversight of Pharmacovigilance responsibilities for JBV's products

Past Experience

  • Market Access Manager
    December 2012 --- September 2013
    Securing reimbursement for innovative medication in Belgium and GD Luxemburg

  • Brand Team Lead Brilique
    November 2010 --- November 2012
    Prepare as a Brand Team Lead the launch of ticagrelor in Belgium and GD Luxemburg

  • Brand Manager Respi
    October 2008 --- November 2010
    Act as a Brand Team Lead for Symbicort in asthma and COPD

  • Manager Clinical Scientists Rheumatology
    January 2008 --- August 2008
    Manage a European team of clinical scientists (6)

  • Clinical Scientist Rheumatology
    January 2006 --- December 2007
    Act as medical afffairs liason for Remicade in the rheumatological indications

  • Clinical Scientist Cardiology
    October 2004 --- December 2005
    Act as a medical affairs liaison for abciximab in Belgium, France, Luxemburg and the Netherlands

  • PhD student
    January 1997 --- January 2004
    PhD

  • PhD Student
    January 1997 --- January 2004
    PhD

Personality

BrightOwl Assessment :
Impulse commandApproachabilityPerspectiveCuriosityAdaptabilityKindnessStrivingDependabilityWillingness to compromiseInterest in knowledgeCreative thinking
Self Assessment :
ResiliencyCharmEfficiencyDependabilityTrustAdaptabilityAnger commandImpulse commandInterest in knowledgeOptimismReaction to stressIndependenceApproachabilityEmotional reactivitySelf-confidenceCreative thinkingCuriosityWillingness to compromisePerspective

Knowledge

BrightOwl Assessment :
Understand levels of research evidencePhases of clinical development (phase I to IV)Project ManagementScientific methodologyFrenchscienceLifesciencesUnderstand how results translate to practicePrinciples and ethics of clinical research
Self Assessment :
Allergy and immunologyCardiovascular diseasesEmergency medicineGastroenterologyGeneral practiceInfectious diseasesPediatricsRheumatologyUnderstand levels of research evidenceDermatologySearch literature on clinical trialsInterpret clinical trial resultsInterpret systematic reviewsUnderstand how results translate to practicePhases of clinical development (phase I to IV)Drug development processPulmonary diseasesClinical trial designStudy outcomes and outcome measuresPrinciples and ethics of clinical researchStatistical considerations in design and analysisQuality of Life (QoL) outcomesDrug Safety and PharmacovigilanceProject ManagementActions and modes of action of human physiologyMarketing Authorisation Application (MAA)Writing Study Procedures and SOPsSafety concerns (such as therapeutic ratio with respect to possible adverse effects)Phase IIIPhase IVDrug safety assessmentLifesciencesFrenchPharmacogenomics (study of genetic variation)Safety trialsCardiologyTeamworkRegulatory submissionsSales EffectivenessPharmaceutical IndustryBiotechnologyClinical trialsPCRHematologyHealthcare industryCTMSEnglishInternal medicinescience
LinkedIn Assessment :
ImmunologyCardiologyClinicalRheumatologyBiotechnologyLife SciencesPharmaceuticalsInfectious diseasesR&Dmolecular biologyscienceEnzyme-linked immunosorbent assay (ELISA)MicrobiologyBiochemistryPCRpharmacologyHospitalsLifesciencesClinical researchPharmaceutical IndustryClinical trialsClinical DevelopmentMedical affairsoncologyMedical writingHematologyFlow CytometryPharmaceutical salesTherapeutic AreasPharmacovigilanceVaccinesBiopharmaceuticalsMarket accessRegulatory affairsVirologyNeuroscienceDermatologyHospital SalesICH-GCPGastroenterologyPharmaceuticsNeurologyRegulatory submissionsCRODiabetesSales EffectivenessMedicineHealth EconomicsEndocrinologyOsteoporosis

Skills and Expertise

BrightOwl Assessment :
Act as the main line of communication between the sponsor and the investigatorAnswer, transfer and handle incoming calls as needed.Coach and provide guidance to clinical staff.Direct co-workers to achieve resultInteract with pre-clinical scientistsInterpret dataLiaise with professionals in other divisions of the company as requiredWork collaboratively with the other members of the clinical research team lifescience

Education

  • Doctor of Philosophy (PhD) in Immunology/Parasitology from Vrije Universiteit Brussel in 2004
  • PhD in Immunology from Vrije Universiteit Brussel in 2004
  • PhD in Applied Biological Sciences (immunology) from Vrije Universiteit Brussel in 2004

Area / Region

Brussels

Others

Driving License
  • Yes